Agilon Health Inc.

NYSE: AGL · Real-Time Price · USD
1.11
0.05 (4.72%)
At close: Aug 15, 2025, 3:59 PM
1.10
-1.35%
After-hours: Aug 15, 2025, 07:53 PM EDT

Agilon Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-104.37M 12.11M -105.79M -126.85M -30.68M 3.22M -167.09M -31.48M -16.8M 15.96M -56.55M -30.74M -20.73M 1.16M -56.74M -35.96M -298.94M -15.15M
Depreciation & Amortization
7.32M 6.88M 6.49M 6.22M 5.91M 5.84M 4.74M 5.31M 5.51M 4.19M 3.91M 3.45M 3.04M 3.37M 3.64M 3.94M 3.61M 3.48M
Stock-Based Compensation
15.38M 16.72M 2.28M 13.26M 18.21M 16.91M 15.52M 20.74M 19.57M 13.67M 9.95M 7.91M 6.55M 3.97M 4.41M 11.96M 274.55M 1.47M
Other Working Capital
52.88M -38.79M 105.77M 67.31M -3.98M -63.34M 95.62M 6.27M -20.49M -91.47M -65.55M 16.95M -46.31M -30.25M -26.76M 2.59M -16.63M -33.58M
Other Non-Cash Items
9.09M -28.9M 7.67M 32.35M 21.85M 18.19M -10.22M -15.06M -10.08M -3.16M -74.18M 764K -2.81M -1.48M 10.42M -2.12M 245K 1.77M
Deferred Income Tax
n/a n/a n/a n/a 417K n/a 267K 1.21M 1.07M n/a 66.73M n/a n/a n/a -3.23M 452K -2.13M 1.19M
Change in Working Capital
52.88M -38.79M 105.77M 67.31M -3.98M -63.34M 95.62M 6.27M -20.49M -91.47M 182K 16.95M -46.31M -30.25M -7.4M 2.59M -16.63M -33.58M
Operating Cash Flow
-35.09M -31.99M 16.42M -7.7M -18.72M -47.78M -61.17M -13.02M -21.2M -60.81M -49.96M 2.65M -60.26M -23.23M -48.9M -19.14M -39.29M -40.83M
Capital Expenditures
-3.25M -10.88M -12.42M 14.36M -9.77M -14.58M -15.38M -5.79M -5.93M -3.72M -8.31M -3.68M -15.62M -5.05M -3.47M -5.29M -500K -4.16M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 1.42M -112K -1.84M -44.37M -500K n/a 500K 500K 1.3M n/a 1.06M -3.71M
Purchase of Investments
-12.64M -47.52M n/a n/a -12.01M n/a -7.64M -41.45M -35.6M -29.97M -35.08M -138.11M -285.08M -683K n/a n/a n/a n/a
Sales Maturities Of Investments
90.03M 35.31M 40.09M 51.08M 41.22M 74.52M 30.15M 36.63M 68.73M 28.54M 37.42M 10.85M 3.6M 683K n/a n/a n/a n/a
Other Investing Acitivies
-1M -7.03M -13.15M -18.88M -1.23M -8.51M -10.75M -310K -5.33M -1.3M -1.5M -4.28M -7K -4.32M -435K -6.27M -67.83M -1.2M
Investing Cash Flow
70.46M -23.09M 23.67M 46.56M 18.22M 51.44M -2.2M -11.03M 20.03M -50.81M -7.97M -130.94M -296.61M -8.87M -2.6M -11.56M -67.26M -9.07M
Debt Repayment
n/a n/a n/a -1.25M -1.25M -1.25M n/a -1.25M -1.25M -1.25M -1.25M -1.25M -1.25M -1.25M -1.25M 1K -50M 31.35M
Common Stock Repurchased
-2.58M -161K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a -1.25M n/a n/a n/a n/a n/a n/a n/a 11.67M -160K -8.16M -1.05M
Financial Cash Flow
-2.58M -161K -22K -1.41M -1.71M 559K -845K 1.41M -202.04M 8.34M 1.13M 9.11M 4.31M 13.51M 10.42M 896K 1.11B 30.3M
Net Cash Flow
32.79M -55.24M 40.07M 37.45M -2.21M 4.22M -64.21M -22.64M -203.21M -103.29M -56.8M -119.18M -352.56M -18.6M -41.08M -29.81M 1.01B -19.6M
Free Cash Flow
-38.34M -42.87M 4M 6.66M -28.48M -62.35M -76.55M -18.8M -27.14M -64.53M -58.27M -1.03M -75.89M -28.28M -52.37M -24.44M -39.79M -44.99M